Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.
about
Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cellsPlatelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and futureInteraction between Mesenchymal Stem Cells and B-CellsMesenchymal stem cells and immunomodulation: current status and future prospectsTreatment of chronic graft-versus-host disease in 2011Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsTracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles.Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.The establishment of a bank of stored clinical bone marrow stromal cell products.Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis.Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model.Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeuticsMesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacitiesMesenchymal stem cells - a promising therapy for Acute Respiratory Distress SyndromeEfficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice.Challenges for heart disease stem cell therapy.Mesenchymal stromal cells: a new tool against graft-versus-host disease?The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation ProcessAdipose-Derived Mesenchymal Stem Cells Restore Impaired Mucosal Immune Responses in Aged MiceTherapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation.Adult human mesenchymal stromal cells and the treatment of graft versus host disease.Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action.Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease.Multipotent mesenchymal stromal cell therapy and risk of malignancies.Mesenchymal stromal cells (MSCs): science and f(r)iction.Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde?Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology.Stromal cells-are they really useful for GVHD?Alveolar bone loss: mechanisms, potential therapeutic targets, and interventions.Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells.Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.Focal adhesion kinase signaling regulates anti-inflammatory function of bone marrow mesenchymal stromal cells induced by biomechanical force.Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.Remestemcel-L for the treatment of graft versus host disease.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.
P2860
Q21245484-98152D9D-11F9-41F9-AC71-DF19F51CE0B5Q26740490-32FB7AB2-08D8-481F-A602-1324E85BD1B1Q26750859-BBAE128A-39F2-404D-A2B5-581D54FDEE00Q26770191-D8A6567A-737E-4B60-A265-1908EC5AFDD0Q26851433-A25B89DB-3285-4401-8ADC-E5001B888CE4Q28071916-C6A67824-EE0E-47ED-99D4-183BFD6F4A90Q28079823-AABC02F5-2B26-4219-8C9C-9E796263A689Q30532793-DBC1AAFF-8569-4ADC-A770-7469EE06B93AQ33397784-D3B428C8-C881-482E-ACE9-EF69556DBAB4Q33454406-08D76559-B05A-4B13-A9EE-63AB59B8BD9DQ33774583-B000C070-C4B7-4D2F-BF82-2576CE65328CQ34038572-02C5E45F-B80F-43AC-AF8F-D7F61FB6F71AQ34038854-007CE5E0-0F26-4FBC-99C6-8E1B035D5D2CQ34422955-8BFDAC1A-BDCD-4771-928D-3A58719A669CQ35017103-DBA247CD-BD52-4118-A9C7-3120ED4339E1Q35652003-9BF409CC-F3EE-4DA0-BA22-73A9FCDAC617Q35760517-F96DD44D-A57E-4F6E-807E-ACF44ED2BA2AQ35797189-7C99A1C3-7617-4320-BCE4-D596D22FE191Q35808738-B35F8A93-3307-43CE-A41C-BB35613875D6Q35848391-840C5822-F7BC-43A2-B350-B11A42202B9AQ35889780-3EF29785-C211-48DA-B796-C4A3783F034CQ35912989-0C3A01AC-F6B4-485D-A0E7-4C80F6C4AEE8Q36998206-748808D6-EE44-4CEA-8953-42BB697A9037Q37493543-DC245687-DA39-445E-8BD8-C11E4778FC80Q37622055-CB41D95E-00F6-4318-B37C-F2DD2FE4E6C2Q37690626-FEED808D-D9A4-47A2-B77B-9C6BA0A6C0DCQ37970678-BABB3CF5-3919-4BA2-AE96-AC3DB3F6B114Q37975113-D8DAEA69-FD8C-4952-B8EC-923BE8A23867Q38014753-A8039F27-25D5-4684-9471-2B9FEB46C7DCQ38116454-7DD7D66F-8B7D-49A0-A800-6F4E22385163Q38136243-07D43ED8-99E1-49C4-ACA9-43463871C495Q38181957-207BBA39-894C-4E74-8488-A890D3B6D529Q38204892-F5552034-9E3C-4B4B-B393-11334ED78429Q38275024-29DA43CC-D1B1-4FF5-83E4-ECBAA4DC1070Q38393820-DDC242C1-8771-446F-B6F4-7FECA1F394C2Q38694213-60CD15CB-8285-40AE-9605-E237F17A398FQ38710399-3D5F206C-CE0B-4054-8B6C-521406CB2CD2Q38775114-5F397618-883A-463A-8E6B-A35D678CE8F4Q38892351-B076A5AB-E759-48F0-B991-84339D649CDEQ39012031-B37C2BD2-5098-41A0-81DA-751E2981F176
P2860
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mesenchymal stem cells expande ...... f a phase I/II clinical trial.
@ast
Mesenchymal stem cells expande ...... f a phase I/II clinical trial.
@en
type
label
Mesenchymal stem cells expande ...... f a phase I/II clinical trial.
@ast
Mesenchymal stem cells expande ...... f a phase I/II clinical trial.
@en
prefLabel
Mesenchymal stem cells expande ...... f a phase I/II clinical trial.
@ast
Mesenchymal stem cells expande ...... f a phase I/II clinical trial.
@en
P2093
P2860
P50
P1433
P1476
Mesenchymal stem cells expande ...... of a phase I/II clinical trial
@en
P2093
Carmen Martinez
Consuelo Del Cañizo
Jose A Pérez-Simon
José Rifón
Sandra Muntion
P2860
P304
P356
10.3324/HAEMATOL.2010.038356
P577
2011-03-10T00:00:00Z